Research Studies

Status: Recruiting
Study area: Oncology
Principal investigator: Leanna Standish, PhD, ND, LAc, FABNO
Funded by: Bastyr University
Project period: 01/01/2014- 12/31/2018

This observational study seeks to describe the outcomes for individuals who choose to receive integrative oncology care. We will report on clinical outcomes of our patients in terms of whether cancer comes back after treatment (recurrence rates) and survival. We are also interested in identifying therapies recommended to our patients and length of hospice stay when applicable. You will not directly benefit from the study, but information gathered during the course of this study may help us begin to assess the longer-term effects of integrative naturopathic, traditional, Chinese and palliative medicine on cancer patients. To read more about this study, please click on the study title above.

Status: Active
Study area: Oncology
Principal investigator: Leanna J. Standish, ND, PhD, LAc, FABNO; M. Robyn Andersen, PhD
Funded by: Primary funding by: NIH/NCCAM Grant No. 1R01AT005873; Study Expansion funding by: Lotte & John Hecht Foundation
Project period: 8/1/10 – 12/31/18

PURPOSE: This NIH-NCCAM funded epidemiologic research is being conducted as an observational prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and Integrative Oncology (IO) and their effects on breast cancer patients in community settings.
Clinicaltrials.gov: NCT-1366248.
This study is ongoing but not recruiting new participants.

Status: Active
Study area: Oncology
Principal investigator: Leanna Standish, ND, PhD, LAc, FABNO
Funded by: Bastyr Integrative Oncology Research Center
Project period: ongoing
Published in:

Founded in 2009, BIORC evaluated the effectiveness of integrative oncology care in our cancer patients. It has now merged with the BOS study.

Status: Recruiting
Study area: Neurology
Principal investigator: Laurie Mischley, ND,MPH, PhD(c)
Project period: 12/21/10 – 12/31/2015

The goal of this study is to collect as much data as possible over a five-year period with the hope of finding dietary and lifestyle factors associated with a slower disease progression. To participate in or read more about this study, please click on the study title above.

Status: Recruiting
Study area: Neurology
Principal investigator: Laurie K Mischley, ND, MPH, PhD(c)
Project period: 09/01/2012 - 08/31/2017

The goal of this PD study is to collect as much data as possible over a five-year period with the hope of finding dietary and lifestyle factors associated with a slower disease progression.
To participate in or read more about this study click on the study title above.

Status: Recruiting
Study area: Neurology
Principal investigator: Laurie Mischley, ND, MPH, PhD(c)
Funded by: Michael J. Fox Foundation
Project period: 12/31/2014-12/30/2016

This is a Phase II study seeking to determine whether administration of different doses of glutathione or placebo, as a nasal spray, improves Parkinson’s disease (PD) symptoms over time in a population of individuals with PD.

Status: Recruiting
Study area: Neurology
Principal investigator: Laurie Mischley, ND, MPH, PhD(c)
Funded by: Charles and Barbara Wright Multiple Sclerosis Research Fund
Project period: 10/17/12-2/28/16

This case-control study will recruit individuals with a diagnosis of MS and healthy controls. Individuals will be asked to come to Bastyr Clinical Research Center for a single study visit, at which time dietary intake, current medications and supplements, other medical diagnoses, and coagulation will be evaluated.

Status: Completed
Study area: Neurology
Principal investigator: Laurie Mischley, ND, MPH
Funded by: NIH/NCCAM
Project period: 01/01/10 - 12/31/14

Parkinson's disease (PD) is considered a progressive and irreversible neurodegenerative disease. Current therapies improve disease symptoms, however none alter the underlying degenerative course. Research suggests the loss of brain glutathione, a powerful antioxidant, is one of the earliest changes to occur in the brain of PD patients and the magnitude of glutathione depletion parallels the severity of PD. This study will look at the use of intranasal glutathione in PD patients to determine safety, tolerability, and the impact on PD symptoms.

Status: Active
Study area: Oncology
Principal investigator: Leanna Standish, ND, PhD, LAc, FABNO; Mary L. (Nora) Disis, MD
Co-investigator(s): Lupe Salazar, MD, Hailing Lu, MD, PhD, Erin Sweet, ND
Funded by: NIH/NCCAM/NCI (U19) Partnership with University of Washington
Project period: 09/29/2010 - 08/31/2014

A Clinical Trial of Mushroom (PSK) for Treatment of Breast Cancer, The Bastyr University/University of Washington PCCTR Oncomycology Research Center will investigate the immunologic and antitumor effects of Trametes versicolor (Tv) a traditional Chinese medicine medicinal mushroom, for use in the treatment of breast cancer patients in the U.S. This study is not yet recruiting.

Status: Active
Study area: Chronic Disease
Principal investigator: Ryan Bradley, ND, MPH
Co-investigator(s): Marisa Pellegrini, ND
Funded by: BU Faculty Seed Grant
Project period: 4/1/13-6/30/14

This study will evaluate quercitin’s effects on blood glucose and blood vessel function (endothelial function) in patients with type 2 diabetes in comparison to placebo and Acarbose, a pharmaceutical anti-diabetic agent. The study is no longer recruiting and is in data analysis phase.

Pages